Vaccination

EU watchdog backs Sanofi COVID booster jab

The EU on Thursday approved a COVID booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

Vaccination

Sanofi-GSK COVID booster jab shows positive results

French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.

Diseases, Conditions, Syndromes

GSK and Vir step up virus antibody treatment trials

British pharmaceutical giant GlaxoSmithKline (GSK) and Californian laboratory Vir Biotechnology on Tuesday announced final stage testing of their potential coronavirus treatment.

Diseases, Conditions, Syndromes

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus epidemic.

Diseases, Conditions, Syndromes

Britain's GSK joins race to develop China virus vaccine

UK pharmaceuticals giant GlaxoSmithKline (GSK) said Monday it was joining a global race to develop a vaccine for a new strain of a coronavirus that has killed more than 360 people.

page 2 from 7